Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors.AuthorsMarshall, John; Hwang, Jimmy; Eskens, Ferry; Burger, Herman; Malik, Shakun; Uttenreuther-Fischer, Martina; Stopfer, Peter; Ould-Kaci, Mahmoud; Cohen, Roger; Lewis, NancyPublicationInvestigational New Drugs, 2013, Vol 31, Issue 2, p399ISSN0167-6997Publication typeArticleDOI10.1007/s10637-012-9890-y